Person: Dr Ted Hewitt

Dr Daniel Podolsky

Dr Daniel Podolsky and Dr Roderick Flower have joined the board of directors of Calgary’s Antibe Therapeutics Inc, an early-stage developer of drugs for inflammatory and cardiovascular diseases. Dr Podolsky is a professor of medicine at Harvard Univ and chief of gastroenterology at Massachusetts General Hospital. He is regarded as a leading authority on inflammatory…

Dr Ted Hewitt

Dr Ted Hewitt has been appointed VP research at the Univ of Western Ontario, a position he has held in an acting capacity since November/04 (R$, October 12/04). Hewitt assumed the position while he was associate VP research and international relations, following the departure of Dr Nils Petersen who was appointed DG of the National…

Dr Ted Hewitt

Dr Ted Hewitt has been appointed acting VP research at the Univ of Western Ontario (UWO), replacing Dr Nils Petersen, who has left to become DG of the National Institute for Nanotechnology in Edmonton (R$, June 15/04). Hewitt is currently UWO’s associate VP research and will assume the acting position November 1. A selection committee…

Louise Comeau

Louise Comeau has been appointed president and CEO of Fuel Cells Canada (FCC), replacing the retiring Dr Ron Britton. Comeau comes to FCC with an extensive background in sustainable development, most notably holding a senior position with the Federation of Canadian Municipalities’ Ottawa-based Centre for Sustainable Community Development. She has also served on a number…

Tom Wright

Tom Wright has been appointed executive director of Technology Partnerships Canada (TPC), replacing Jeff Parker who has been appointed the federal government’s consul general in Seattle WA (R$, May 27/04). Wright comes to TPC from Industry Canada where he was DG and manager of the environmental affairs branch. He is a board member of the…

Dr Henrich Guntermann

Dr Henrich Guntermann has been appointed by the new board of directors of Dimethaid Research Inc, replacing embattled CEO Rebecca Keeler who was ousted by a new board last month. Guntermann is a German-based medical doctor and entrepreneur who will re-locate to Toronto from Germany. Dimethaid’s largest creditor is German businessman Friedrich Kuhne who is…